Close Menu

Molecular Health

The planned product, which will target drug-development companies, uses machine learning techniques to predict the outcomes and likelihood of success of clinical trials.

Molecular Health will make its analysis tools available to aid in the interpretation of raw data generated by customers of Agena's MassArray system.

The Workbench Manager helps labs manage their bioinformatics workflows while the Clinical Annotation software offers clinical variant interpretation services.

Molecular Health has renamed its portfolio ahead of planned product launches and an early-access program for its drug safety software starting in January.

The company will use the funds to continue building out its commercial platform and to drive product adoption.

Makers of NGS cancer profiling diagnostics lauded the preliminary proposal, but pointed out areas where the coverage criteria may miss patients who might benefit from testing.

The company's results add to a growing body of evidence, including from Foundation Medicine, that suggests such techniques have clinical utility for patients. 

MolecularHealth announced that Fadi Braiteh has joined its advisory board. Braiteh is an oncologist with Comprehensive Cancer Centers of Nevada, specializing in gastro-intestinal, digestive system, and breast cancers.

Diagnostics firm Epic Sciences has appointed Greg Lucier as chairman of its board of directors.

Pages

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.